In TP53 wild-type CLL cells, HDM201 induced a concentration-dependent stabilization of p53, which was accompanied by the activation of p53 target genes, CDKN1A (encoding the p21WAF1 protein) and MDM2 (Figure 3A). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.